Down Syndrome — Efficacy Study of Folinic Acid to Improve Mental Development of Children With Down Syndrome
Citation(s)
One-year Double-blind Placebo-controlled Phase 2-3 Study to Evaluate the Effect of Oral Folinic Acid Treatment (1mg/kg/d) on the Psychomotor Development of Young Down Syndrome Patients